Ondansetron HCL 4 MG tablet 500S
Ended Awarded Last action
- Contract number
- SPE2DR26FK953
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,225
Award facts
- Contract value 100% obligated
- $28,224.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $28,224.88 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCl 4 mg tablets (500 count) on January 15, 2026, with an ultimate completion date of January 16, 2026. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the federal procurement process. The place of performance is listed as Conshohocken, Pennsylvania, which serves as the company's corporate headquarters. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (formerly known as AmerisourceBergen), a major pharmaceutical distributor and critical vendor for federal medical procurement needs.
This delivery order is executed under AmerisourceBergen's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The parent company, Cencora, Inc., holds an even larger IDC with DLA valued at up to $999,999,999.00 through December 31, 2031, which serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. Ondansetron is an antiemetic medication commonly used in military treatment facilities and veteran healthcare systems to manage nausea and vomiting.
Quick answers
Who was awarded contract SPE2DR26FK953?
SPE2DR26FK953 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26FK953 worth?
The government has obligated $28,225 on SPE2DR26FK953.
Is contract SPE2DR26FK953 an order under another contract?
Yes. SPE2DR26FK953 is a delivery order under SPE2DR25D1104, an indefinite delivery contract.
Was contract SPE2DR26FK953 competed?
The extent of competition for SPE2DR26FK953 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award